US Stock MarketDetailed Quotes
APLS Apellis Pharmaceuticals
- 28.740
- -0.090-0.31%
Close Nov 7 16:00 ET
3.58BMarket Cap-14157P/E (TTM)
29.050High27.730Low2.10MVolume28.670Open28.830Pre Close60.15MTurnover2.48%Turnover RatioLossP/E (Static)124.39MShares73.80052wk High15.08P/B2.43BFloat Cap24.34052wk Low--Dividend TTM84.64MShs Float94.750Historical High--Div YieldTTM4.58%Amplitude11.450Historical Low28.675Avg Price1Lot Size
Apellis Pharmaceuticals Stock Analyst Ratings & Price Target
Price Target
Updated: Nov 7, 2024
The average Apellis Pharmaceuticals stock price target is 47.07 with a max estimate of 75.00 and a min estimate of 30.00
Review Apellis Pharmaceuticals earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Analysis
Price Target
Updated: Nov 7, 2024
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
